|
| Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Bullion ~ Forex ~ Sports ~ Technology ~ Health ~ Features |
| Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack ~ All Health Topics |
|
Home
/ Health News / 2008 / September 2008 / September 24, 2008 Lung disease-inhalers can cause heart attacks |
Herbal supplement Ginkgo does not prevent Alzheimers disease
Novel electronic machine speeds wound healing in pigs
Why past oral contraceptive use lowers ovarian, uterine cancer risk
How binge drinking drives heart disease
Lack of exercise put depressed heart patients at greater risk
How cancer prevention drives aging
For the first time, researchers have found how cellular senescence, the well-known mechanism for preventing cancer, can trigger aging and age-related disease by changing the local tissue environment. ANI
Scientists unveil genes vital to vital to adult heart function
In a study on fruit fly Drosophila, scientists at the Burnham Institute for Medical Research (Burnham) have found that genes involved in embryonic heart development are vital to adult heart function in both fruit flies and humans. ANI
Psychiatric disorders common among college-aged
A new study has revealed that psychiatric disorders appear to be common among 18- to 24-year-olds, with overall rates similar among those attending or not attending college. ANI
Inhalers prescribed for a lung disease can cause heart attacks, a shocking new research has found.
London, Sept 24 : Inhalers prescribed for a lung disease can cause heart attacks, a shocking new research has found.
According to the study, anticholinergic drugs contained in the inhalers could increase the risk of a heart attack, cardiovascular death or stroke by more than 50 percent.
The inhalers are helpful for people with chronic obstructive pulmonary disease (COPD), which includes chronic bronchitis and emphysema, to breathe.
They open up the airways by relaxing muscles, which allows air to get in and out of the patient's lungs more easily.
To reach the conclusion, the researchers looked at the inhalers ipratropium (Atrovent) and tiotropium (Spiriva). The meta-analysis examined at 17 medical trials involved a total of 14,783 patients who were using the inhalers for more than 30 days.
The study has been published in the Journal of the American Medical Association (JAMA).
"Inhaled anticholinergic use for more than 30 days significantly increases the risk of cardiovascular death, myocardial infarction (heart attack), or stroke in patients with COPD by approximately 58 percent," the Daily Express quoted the researchers, as saying.
The research was carried out by experts from the Wake Forest University School of Medicine in North Carolina and Dr Yoon Loke, from the University of East Anglia in Norwich.
ANI
